Julie A. Panepinto, MD, MSPH

Titles
Pediatric hematologist; director, Center for Clinical Effectiveness Research, Children's Research Institute;  director, Comprehensive Stroke program,  director, Clinical Research Sickle Cell Disease Comprehensive program, Children's Hospital of Wisconsin; professor, Pediatrics, Hematology/Oncology/BMT, Medical College of Wisconsin.

Division
Hematology, Oncology and Transplant.

Research interests
Clinical effectiveness and outcomes, health disparities, and health services.

Education
Medical degree, Southern Illinois University School of Medicine, Springfield, 1991; MSPH, Epidemiology, University of Colorado Health Sciences Center, Denver, 1997; residency, Pediatrics, University of Wisconsin Hospital and Clinics, Madison, 1994; fellowship, Pediatric Hematology/Oncology/Bone Marrow Transplant, University of Colorado Health Sciences Center, Denver, 1997; intensive course in Cancer prevention and control - focus on Epidemiology of Cancer and it's prevention, National Cancer Institute, 1996; Mid-career Women Faculty Professional Development seminar, Association of American Medical Colleges, 2002; Clinical Research Scholars program - project focus: Health-related Quality of Life in Children with Sickle Cell Disease, NIH K30 program, Medical College of Wisconsin, 2007; Hedwig van Ameringen Executive Leadership in Academic Medicine Fellow (ELAM), Institute for Women's Health and Leadership, Drexel University College of Medicine, Philadelphia, PA, 2112.

Certifications
Pediatrics, Pediatric Hematology/Oncology

Honors
Health Care Financial Management Association Award for outstanding thesis in health economics, 1997; Faculty Teaching Award, Brown University/Rhode Island Hospital, 2000; Named Best Doctor by Best Doctors, Inc., 2006-2010; Outstanding Medical Student Teacher, Medical College of Wisconsin, 2010.

Representative publications

• Panepinto JA, O'Mahar KM, DeBaun MR, Rennie KM, Scott JP. Validity of the Child Health Questionnaire for Use in Children with Sickle Cell Disease. J Pediatr Hematol Oncol. 2004; 26(9): 574-8.
• Panepinto JA, Brousseau DC, Hillery CA, Scott JP. Variation in Hospitalizations and Hospital Length of Stay in Children with Vaso-Occlusive Crises in Sickle Cell Disease. Pediatr Blood Cancer. 2005; 44(2):182-6.
• Panepinto JA, O'Mahar KM, DeBaun MR, Loberiza FJ, Scott JP. Health-related Quality of Life in Children with Sickle Cell Disease: Child and Parent Perception. British Journal of Haematology. 2005; 130: 437-444.
• Brousseau DC, Owens PL, Mosso AL, Panepinto JA, Steiner CA. Acute Care Utilization and Rehospitalizations for Sickle Cell Disease. JAMA. 2010; 303(13):1288-1294.
• Monica L Hulbert, Robert C McKinstry, JoAnne L Lacey, Christopher J Moran, Julie A Panepinto, Alexis A Thompson, Sharada A Sarnaik, Gerald A Woods, James F Casella, Baba Inusa, Jo Howard, Fenella Jimpact, F Kirkham, Kofi Anie, Jonathan E Mullin, Rebecca Ichord, Michael Noetzel, Yan Yan, Mark Rodeghier, and Michael R. DeBaun. Silent Cerebral Infarcts Occur Despite Regular Blood Transfusion Therapy after First Stroke in Children with Sickle Cell Disease. Blood. 2011; 117:772-779.
• JA Panepinto, PL Owens, Al Mosso, CA Steiner, and DC Brousseau. Concentration of Hospital Care for Acute Sickle Cell Disease-related Visits. Peds Blood and Cancer. In press, 2011.

Grants

• Silent Infarct Transfusion Trial (SITT), National Institutes of Health, co-investigator.
• Improvement of Communication Process and Outcomes after Newborn Genetic Screening, National Health, Lung and Blood Institute, co-investigator.
• Assessing Decision Making in Visits by Children with Chronic Disease, Institute for Clinical and Translational Research, University of Wisconsin, consultant.
• Expansion of a Randomized Educational Rehabilitation Trial for Students with Sickle Cell Disease and Memory Deficit, American Society of Hematology, co-investigator.
• The Development of the PedsQL in Sickle Cell Disease, National Heart, Lung and Blood Institute, principal investigator.
• Quality of Life After Treatment with Magnesium for Acute Sickle Cell Pain Episode, National Heart, Lung and Blood Institute, principal investigator.

Contact
MACC Fund Research Center
8701 Watertown Plank Road
Wauwatosa, WI 53226
Phone: (414) 955-4170
Fax: (414) 456-6543
E-mail: jpanepin@mcw.edu